Colony Bankcorp (NASDAQ:CBAN – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday.
Colony Bankcorp Stock Performance
Shares of CBAN opened at $17.62 on Thursday. The company has a 50-day simple moving average of $15.86 and a 200-day simple moving average of $14.12. The company has a quick ratio of 0.80, a current ratio of 0.81 and a debt-to-equity ratio of 0.90. The company has a market capitalization of $308.88 million, a PE ratio of 14.10 and a beta of 0.57. Colony Bankcorp has a 52-week low of $10.33 and a 52-week high of $18.42.
Colony Bankcorp (NASDAQ:CBAN – Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $0.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.34 by $0.01. The business had revenue of $44.69 million during the quarter, compared to the consensus estimate of $28.67 million. Colony Bankcorp had a net margin of 12.75% and a return on equity of 8.86%. During the same quarter last year, the firm posted $0.34 EPS. Equities research analysts predict that Colony Bankcorp will post 1.38 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Colony Bankcorp
About Colony Bankcorp
Colony Bankcorp, Inc operates as the bank holding company for Colony Bank that provides various banking products and services to commercial and consumer customers. The company offers deposit products, including demand, savings, and time deposits. It also provides loans to small and medium-sized businesses; residential and commercial construction, and land development loans; commercial real estate loans; commercial loans; agri-business and production loans; residential mortgage loans; home equity loans; and consumer loans.
Featured Articles
- Five stocks we like better than Colony Bankcorp
- How to Read Stock Charts for Beginners
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Use the MarketBeat Excel Dividend Calculator
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 5 Top Rated Dividend Stocks to Consider
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Colony Bankcorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colony Bankcorp and related companies with MarketBeat.com's FREE daily email newsletter.